PF3D7_0714400

PF3D7_0714400 encodes the Plasmodium falciparum calmodulin, a single-copy, intron-containing gene on chromosome 14 whose product functions as a calcium-sensing signaling hub during the intraerythrocytic cycle (PMID:1852174, PMID:1915742, PMID:16809343). Its mRNA and protein are developmentally regulated, peaking in the late trophozoite/early schizont stage through control at both transcription and RNA stability (PMID:8720124), and the protein localizes diffusely in the cytoplasm and concentrates at the apical end of merozoites, near the rhoptry ductule (PMID:3313391, PMID:26689736). Calmodulin acts as a calcium-dependent activator of multiple downstream effectors: it binds and activates P. falciparum protein kinase B (PfPKB) through a mapped N-terminal calmodulin-binding domain (PMID:16809343), which in turn associates with the actin-myosin motor and phosphorylates the glideosome component PfGAP45, linking Ca2+/calmodulin signaling to erythrocyte invasion (PMID:18165240); it stimulates the calcineurin/PP2B phosphatase (PMID:10340482) and physically interacts with PP7 phosphatase and CDPK1 (PMID:39387582); and it supports Ca2+-dependent kinase activity attributed to PfPK2 (PMID:18762219). Pharmacological antagonism of calmodulin blocks merozoite invasion and schizont maturation (PMID:3127214), and manipulation of calmodulin levels alters cytosolic Ca2+ dynamics and calcium-dependent proteolysis, implicating it in intracellular calcium homeostasis (PMID:26689736, PMID:29913151). Structurally, the crystal structure of the protein in complex with melittin reveals an ensemble of co-existing binding modes anchored at its hydrophobic pockets (PMID:36906144), and biophysical comparison shows it is only modestly divergent from human calmodulin, with higher C-terminal thermostability but similar inhibitor affinities and target-activation behavior (PMID:32821880).

1. 1987 Medium

   Establishing where calmodulin resides in the parasite and whether it matters for invasion was the first mechanistic question, answered by localizing it to the merozoite apical end and showing antagonists block invasion.

   Evidence radioimmunoassay, immunoelectron microscopy, and in vitro culture inhibition with calmodulin antagonists in P. falciparum

   PMID:3127214 PMID:3313391

   Open questions at the time

   • Antagonist effects are pharmacological and not gene-specific
   • Direct downstream effectors at the apical end not identified at this stage
2. 1991 High

   Defining the gene architecture established that calmodulin is a single-copy, intron-containing gene conserved with other eukaryotic calmodulins and unrelated to chloroquine resistance.

   Evidence Southern blotting, DNA sequencing, primer extension, and Western blot in P. falciparum

   PMID:1852174 PMID:1915742

   Open questions at the time

   • Gene structure does not reveal protein function or partners
3. 1995 Medium

   Whether calmodulin is a constitutive housekeeping factor or a stage-regulated one was resolved by showing its expression peaks in late trophozoite/schizont stages via transcriptional and RNA-stability control.

   Evidence Northern blot, Western blot, and pulse-chase mRNA stability assays in P. falciparum

   PMID:8720124

   Open questions at the time

   • Regulatory factors controlling stage-specific expression not identified
4. 2005 Medium

   Characterizing the calmodulin promoter clarified how its expression is driven, mapping multiple transcription start sites and nuclear-factor binding correlated with poly(dA)poly(dT) tracts.

   Evidence cDNA mapping, deletion reporter assays, and EMSA in P. falciparum

   PMID:15850701

   Open questions at the time

   • Specific trans-acting factors not identified
   • Promoter behavior does not address protein-level mechanism
5. 2006 Medium

   Identifying calmodulin as the calcium-dependent activator of PfPKB, with a mapped binding domain, provided the first direct effector linking calmodulin to a signaling kinase.

   Evidence Co-immunoprecipitation, in vitro kinase assay, and domain mapping in P. falciparum

   PMID:16809343

   Open questions at the time

   • Interaction shown in extracts/in vitro, not by conditional genetics
   • Full effector network downstream of PfPKB incomplete at this stage
6. 2008 Medium

   Connecting the calmodulin-PfPKB axis to the invasion motor answered how calcium signaling engages the glideosome, showing PfPKB phosphorylates PfGAP45 and its inhibition impairs invasion.

   Evidence pharmacological inhibition, invasion assay, Co-IP, and in vitro phosphorylation in P. falciparum

   PMID:18165240

   Open questions at the time

   • Inhibitor-based, not calmodulin-specific genetic evidence
   • In vivo phosphorylation of PfGAP45 by this pathway not directly demonstrated
7. 2008 Medium

   Testing calmodulin dependence of another merozoite kinase showed PfPK2 phosphorylates substrate in a Ca2+/calmodulin-dependent manner, broadening the calmodulin-regulated kinase repertoire tied to invasion.

   Evidence in vitro kinase assay, catalytic-lysine mutagenesis, antagonist treatment, and invasion assay in P. falciparum

   PMID:18762219

   Open questions at the time

   • Direct physical calmodulin-PfPK2 binding not defined
   • Physiological substrate of PfPK2 unknown
8. 1999 Medium

   Establishing that calmodulin functionally activates the parasite PP2B/calcineurin phosphatase extended its role beyond kinases into calcium-dependent dephosphorylation signaling.

   Evidence enzyme purification, in vitro phosphatase assay, and cyclosporin A inhibition in P. falciparum

   PMID:10340482

   Open questions at the time

   • In vitro reconstitution only
   • Cellular consequences of calcineurin activation not defined here
9. 2015 Medium

   Live-imaging localization and calcium dissection addressed calmodulin's role in Ca2+ handling, implicating a calmodulin-related intracellular Ca2+ reservoir and mitochondrial sequestration.

   Evidence knockin live imaging, calcium imaging with fluorescent indicators, and pharmacological dissection in P. falciparum

   PMID:26689736

   Open questions at the time

   • Calmidazolium effects are pharmacological and not calmodulin-specific
   • Molecular identity of the proposed Ca2+ reservoir not resolved
10. 2018 Medium

    Overexpression established a direct causal link between calmodulin abundance and cytosolic Ca2+ dynamics and calcium-dependent proteolysis.

    Evidence transgenic overexpression, calcium imaging, and fluorogenic protease assay in P. falciparum

    PMID:29913151

    Open questions at the time

    • Protease targets of the calcium-dependent activity not identified
    • Loss-of-function counterpart not tested
11. 2020 Medium

    Biophysical comparison to human calmodulin evaluated drug-target selectivity, showing higher parasite C-terminal thermostability but similar inhibitor affinities and target activation.

    Evidence differential scanning fluorimetry/calorimetry, in vitro binding, and enzyme activation assays with recombinant PfCaM and human CaM

    PMID:32821880

    Open questions at the time

    • Functional similarity to host limits selective targeting
    • Cellular validation of Malaria Box compound effects not shown
12. 2022 Low

    In vitro binding to the MyoB IQ2 motif raised the possibility that calmodulin serves as a myosin light chain, expanding its potential structural role in the motor complex.

    Evidence in vitro binding/pulldown assay in P. falciparum

    PMID:36273584

    Open questions at the time

    • Single in vitro pulldown; PfCaM identity as PF3D7_0714400 inferred from context
    • In vivo myosin light-chain role not demonstrated
13. 2023 High

    The crystal structure with melittin defined how calmodulin achieves high-affinity target binding, revealing an ensemble of co-existing sub-optimal binding modes at its hydrophobic pockets.

    Evidence X-ray crystallography and molecular dynamics simulations of PfCaM

    PMID:36906144

    Open questions at the time

    • Melittin is a model peptide, not a physiological parasite target
    • Structures with native effectors (PfPKB, calcineurin) not determined
14. 2024 Medium

    Interaction proteomics identified PP7 phosphatase and CDPK1 as calmodulin partners, adding a further calcium-dependent phosphatase to its effector network.

    Evidence co-immunoprecipitation, conditional knockdown, and phosphoproteomics in P. falciparum

    PMID:39387582

    Open questions at the time

    • Functional consequence of the calmodulin-PP7 interaction not isolated to calmodulin
    • Direct calmodulin-CDPK1 dependence not mechanistically dissected
15. 2026 Low

    Structural prediction and pulldown indicated calmodulin binds up to six copies along the neck of the class XXII myosin PfMyoF, reinforcing a possible light-chain role for a second myosin.

    Evidence AlphaFold structural prediction and pull-down assay in P. falciparum

    PMID:42141018

    Open questions at the time

    • Single pulldown supported by prediction; PfCaM identity inferred from context
    • In vivo stoichiometry and functional role not established

• It remains unresolved whether calmodulin is genetically essential for invasion and which of its many effector interactions are the physiologically dominant ones in vivo, as most links rest on pharmacology, overexpression, or in vitro binding.
• No calmodulin-specific conditional knockout phenotype reported
• Relative in vivo contribution of PfPKB, calcineurin, PP7, and myosin binding not ranked
• Native effector-bound structures absent